GR3023560T3 - Analytical tracers for cancer, particularly malignant breast cancer - Google Patents

Analytical tracers for cancer, particularly malignant breast cancer

Info

Publication number
GR3023560T3
GR3023560T3 GR970401211T GR970401211T GR3023560T3 GR 3023560 T3 GR3023560 T3 GR 3023560T3 GR 970401211 T GR970401211 T GR 970401211T GR 970401211 T GR970401211 T GR 970401211T GR 3023560 T3 GR3023560 T3 GR 3023560T3
Authority
GR
Greece
Prior art keywords
cancer
breast cancer
malignant breast
particularly malignant
tracers
Prior art date
Application number
GR970401211T
Other languages
English (en)
Inventor
Paul Basset
Jean-Pierre Bellocq
Pierre Chambon
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Publication of GR3023560T3 publication Critical patent/GR3023560T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
GR970401211T 1990-11-21 1997-05-26 Analytical tracers for cancer, particularly malignant breast cancer GR3023560T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9025326A GB2250993B (en) 1990-11-21 1990-11-21 Stromelysin-3 and its application in the diagnosis and treatment of malignant breast cancer
PCT/FR1991/000924 WO1992009701A1 (fr) 1990-11-21 1991-11-21 Marqueurs analytiques pour le cancer, notamment pour le cancer malin du sein

Publications (1)

Publication Number Publication Date
GR3023560T3 true GR3023560T3 (en) 1997-08-29

Family

ID=10685753

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970401211T GR3023560T3 (en) 1990-11-21 1997-05-26 Analytical tracers for cancer, particularly malignant breast cancer

Country Status (16)

Country Link
US (1) US5236844A (el)
EP (1) EP0513316B1 (el)
JP (1) JP3516448B2 (el)
AT (1) ATE152179T1 (el)
CA (1) CA2073860A1 (el)
DE (1) DE69125824T2 (el)
DK (1) DK0513316T3 (el)
ES (1) ES2101079T3 (el)
GB (1) GB2250993B (el)
GR (1) GR3023560T3 (el)
HU (1) HU215165B (el)
IE (1) IE914056A1 (el)
NZ (2) NZ260705A (el)
PT (1) PT99562B (el)
WO (1) WO1992009701A1 (el)
ZA (1) ZA919219B (el)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012645A2 (en) * 1992-11-25 1994-06-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education cDNA CLONE FOR HUMAN INDUCIBLE NITRIC OXYDE SYNTHASE AND PROCESS FOR PREPARING SAME
EP0712444A1 (en) * 1993-07-20 1996-05-22 University Of Massachusetts Medical Center In vivo nucleic acid hybridization method
JPH07303482A (ja) 1993-11-30 1995-11-21 Fuji Yakuhin Kogyo Kk 新規なメタロプロテアーゼおよびそれをコードするｄｎａ
EP0685557B1 (en) * 1993-11-30 1998-08-12 Fuji Yakuhin Kogyo Kabushiki Kaisha Novel metalloprotease and dna coding for the same
US6825024B1 (en) 1993-11-30 2004-11-30 Fuji Yakuhin Kogyo Kabushiki Kaisha Metalloproteinase and encoding DNA therefor
US5709999A (en) * 1994-08-12 1998-01-20 Myriad Genetics Inc. Linked breast and ovarian cancer susceptibility gene
US5747282A (en) * 1994-08-12 1998-05-05 Myraid Genetics, Inc. 17Q-linked breast and ovarian cancer susceptibility gene
US5753441A (en) * 1994-08-12 1998-05-19 Myriad Genetics, Inc. 170-linked breast and ovarian cancer susceptibility gene
US5710001A (en) * 1994-08-12 1998-01-20 Myriad Genetics, Inc. 17q-linked breast and ovarian cancer susceptibility gene
US5763415A (en) * 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
WO1997009420A2 (en) * 1995-09-05 1997-03-13 Celltech Therapeutics Limited Dna sequences coding for a human metalloproteinase and variants thereof
US5905027A (en) * 1995-12-27 1999-05-18 Uab Research Foundation Method of diagnosing and treating gliomas
CA2252509A1 (en) * 1996-04-25 1997-10-30 Takeda Chemical Industries, Ltd. Matrix metalloprotease
EP0939824B1 (en) * 1996-10-31 2007-06-06 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US20050153373A1 (en) * 1996-10-31 2005-07-14 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US20050202499A1 (en) 1996-10-31 2005-09-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US20030165971A1 (en) * 1996-10-31 2003-09-04 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
AU722819B2 (en) * 1996-12-06 2000-08-10 Urocor, Inc. Diagnosis of disease state using mRNA profiles
WO1998040475A1 (en) * 1997-03-11 1998-09-17 Abbott Laboratories Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same
JP4427106B2 (ja) 1997-03-18 2010-03-03 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 平滑筋腫を治療および診断するための方法およびキット
US7332270B1 (en) 1997-03-24 2008-02-19 Urocor, Inc. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US20040072210A1 (en) * 1997-07-07 2004-04-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
WO1999002714A1 (en) * 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1999025850A1 (en) * 1997-11-17 1999-05-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US5972615A (en) * 1998-01-21 1999-10-26 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US7041787B2 (en) * 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
US6600057B2 (en) 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
US20040219551A1 (en) * 2001-07-09 2004-11-04 Petersen Ole William Epsti1, a novel gene induced by epithelial-stromal interaction in human breast cancer
US20030119073A1 (en) * 2001-12-21 2003-06-26 Stephen Quirk Sensors and methods of detection for proteinase enzymes
DE10217254A1 (de) * 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
US20060088899A1 (en) * 2002-05-31 2006-04-27 Alvarez Vernon L Combination chemotherapy with chlorotoxin
US20050193432A1 (en) * 2003-11-18 2005-09-01 Whitehead Institute For Biomedical Research Xenograft model of functional normal and malignant human breast tissues in rodents and methods thereof
US7569662B2 (en) * 2004-01-27 2009-08-04 Compugen Ltd Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
US7667001B1 (en) * 2004-01-27 2010-02-23 Compugen Ltd. Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
US20090191543A1 (en) * 2005-05-27 2009-07-30 Theregents Of The University Of California Identification of rac1b as a marker and mediator of metalloproteinase-induced malignancy
JP2011520914A (ja) 2008-05-15 2011-07-21 トランスモレキュラー， インコーポレイテッド 転移腫瘍の処置
CN102844044B (zh) 2010-02-04 2016-10-26 摩尔弗泰克有限公司 氯毒素多肽和结合物及其应用
JP2013532126A (ja) 2010-05-11 2013-08-15 フレッド ハッチンソン キャンサー リサーチ センター クロロトキシン変異体、コンジュゲート、およびそれらを使用する方法
KR101313184B1 (ko) * 2010-06-24 2013-09-30 한국표준과학연구원 질병 지표 검출 키트 및 질병 지표 검출 방법
RU2015126651A (ru) 2012-12-10 2017-01-16 Фред Хатчинсон Кэнсер Рисёрч Сентер Способы скрининга
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007907A1 (en) * 1986-06-17 1987-12-30 Celltech Limited Process for the production of a protein

Also Published As

Publication number Publication date
PT99562B (pt) 1999-04-30
HU9202368D0 (en) 1992-10-28
DK0513316T3 (da) 1997-05-20
HUT65373A (en) 1994-05-02
EP0513316A1 (fr) 1992-11-19
NZ240688A (en) 1994-09-27
DE69125824T2 (de) 1997-08-07
WO1992009701A1 (fr) 1992-06-11
AU9089691A (en) 1992-06-25
US5236844A (en) 1993-08-17
ATE152179T1 (de) 1997-05-15
JP3516448B2 (ja) 2004-04-05
AU646914B2 (en) 1994-03-10
NZ260705A (en) 1997-05-26
HU215165B (hu) 1998-10-28
GB2250993A (en) 1992-06-24
GB9025326D0 (en) 1991-01-02
ZA919219B (en) 1992-10-28
ES2101079T3 (es) 1997-07-01
PT99562A (pt) 1992-10-30
JPH05505530A (ja) 1993-08-19
EP0513316B1 (fr) 1997-04-23
GB2250993B (en) 1995-02-15
CA2073860A1 (en) 1992-05-22
DE69125824D1 (de) 1997-05-28
IE914056A1 (en) 1992-06-03

Similar Documents

Publication Publication Date Title
HUT65373A (en) Analytical tracers for cancer, particularly malignant breast cancer
IL254264A (en) Doses for treatments using anti-erbb2 antibodies
MX9804009A (es) Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8.
WO2000055180A3 (en) Human lung cancer associated gene sequences and polypeptides
ES8704005A1 (es) Un metodo para evaluar la probabilidad de malignidad celular en una muestra biologica de un haspedante humano.
EP1468014A4 (en) COMPOSITIONS AND METHODS FOR WT1-SPECIFIC IMMUNOTHERAPY
DE69940264D1 (de) Krebsantigene, basierend auf dem tumorunterdrückenden genprodukt wt1
EP0552296A4 (en) Mouse monoclonal antibodies
MY139226A (en) Compositions and methods for wt1 specific immunotherapy
DK0617124T3 (da) Immunreaktivitet overfor udtrykte aktiverede onkogener til diagnose og behandling af maligne svulster
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
HK1052940A1 (en) Synthetic methods for aplidine and new antitumoralderivatives, methods of making and using them
ATE332979T1 (de) Detektion von änderungen von tumor-suppressor genen zur diagnose von krebs
IL149416A0 (en) Human enzymes of the metalloprotease family
GR3021876T3 (en) Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours.
BR0215689A (pt) Composição farmacêutica compreendendo arsênico para o tratamento de malignidade
WO2003037257A3 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
ATE397673T1 (de) Verstärktes krebs-gen wip1
DE502004007950D1 (en) Antitumor wirksame 2-substituierte d-homoestra-1,3,5(10)-trien-3-yl sulfamate
EP1438388A4 (en) IBC-1 (INVASIVE-1 BREAST CANCER), ONCOGEN PRESUME AMPLIFIED IN BREAST CANCER
ATE202284T1 (de) Ein extrakt aus muscheln, extraktionsmethoden und verwendungen davon
WO2003038113A3 (en) Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
WO2000044889A3 (de) Säugetier mit induzierbarem duktalen karzinom in situ
SU1032745A1 (ru) 3-тиосемикарбазон-1,1-дифенилиндандиона, повышающий физическую выносливость
WO2000059934A3 (en) Testis specific protein